Clinicopathological features and treatment outcomes of patients with fibrolamellar hepatocellular carcinoma: a retrospective multicenter study

BACKGROUND: Fibrolamellar Hepatocellular Carcinoma (FLHCC) is a rare primary liver tumour that is distinct from conventional HCC in both histopathological and clinical features. There is no clear consensus on its treatment. OBJECTIVE: Assess the demographics, prognosis, and treatment— particularly s...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Ali Kaan Güren, Hilal Polat, Eyüp Çoban, Emir Çerme, Gizem Bakır Kahveci, Aslı Geçgel, Pınar Ezgi Dama, Lamia Şeker Can, Sedat Biter, Sıla Soylu, Nargiz Majidova, Nadiye Sever, Erkam Kocaaslan, Pınar Erel, Yeşim Ağyol, Abdussamet Çelebi, Rukiye Arıkan, Selver Işık, İlkay Tuğba Ünek, Ertuğrul Bayram, Ozan Yazıcı, Adem Deligönül, Zeynep Hande Turna, Murat Araz, İbrahim Vedat Bayoğlu, Osman Köstek, Murat Sarı
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	King Faisal Specialist Hospital and Research Centre 2025-07-01
סדרה:	Annals of Saudi Medicine
נושאים:	Fibrolamellar HCC Gemcitabine-oxaliplatin Sorafenib Immunotherapy DNAJB1-PRKACA
גישה מקוונת:	http://www.annsaudimed.net/doi/10.5144/0256-4947.2025.249
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!